Trial Profile
Pivotal study of Cabaletta (trehalose) for the treatment of spinocerebellar ataxia type 3 (SCA3)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2020
Price :
$35
*
At a glance
- Drugs Trehalose (Primary)
- Indications Machado-Joseph Disease
- Focus Registrational; Therapeutic Use
- 01 Jul 2015 New trial record